MAgnetic Resonance Imaging-guided implanTation of Cardioverter DEFibrillators
A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 1812 participants.
Also called NCT06269692
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose prevention
- Phase
- Not applicable
- Enrolled
- 1,812 participants
- Registry
-
NCT06269692
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- France
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT06269692. Randomized; no masking; primary purpose prevention. Start 2024-04-01 (anticipated); primary completion 2030-04-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- MAgnetic Resonance Imaging-guided implanTation of Cardioverter DEFibrillators
- Acronym
- SMART-DEF
- Condition
- Myocardial Infarction
- Condition
- Ventricular Tachycardia
- Condition
- Ventricular Fibrillation
- Condition
- Sudden Cardiac Death
- Intervention (Device)
- MRI screening
- Intervention (Device)
- Implantable Loop Recorder
- Intervention (Device)
- Implantable Cardioverter Defibrillator
- Lead sponsor
- Central Hospital, Nancy, France
Record details
- Record id
cardio:ct-nct06269692- Content hash
bb2b6deba8be1a90c6ecdbb4fd9b488b02bcbbf75eeb74e883429df34b2c0061